Homepage | Heart
Heart. is an international journal from BMJ and BCS publishing important research and reviews in cardiovascular disease. Heart is an international peer reviewed journal that keeps cardiologists up to date with important research advances in cardiovascular disease. New scientific developments are highlighted in editorials and put in context with ...
About - Heart
Aims and scope. Heart is an international peer reviewed journal that keeps cardiologists up to date with important research advances in cardiovascular disease. New scientific developments are highlighted in editorials and put in context with concise review articles. There is one free Editor’s Choice article in each issue, with open access ...
Treating patients with ventricular ectopic beats | Heart
Ventricular ectopic beats (VEBs) are commonly seen in daily clinical practice. They are largely asymptomatic but can cause upsetting symptoms in some patients. In normal hearts, their occurrence is usually associated with no clinical significance. However, there are occasions where the presence of VEBs signifies a susceptibility towards more sinister arrhythmias, especially …
Bradyarrhythmias in patients with atrial fibrillation | Heart
The increasing burden of atrial fibrillation (AF) and significant morbidity/mortality associated with this arrhythmia encourage screening it in clinical practice, as recommended in current guidelines. It means opportunistic screening (in patients over 65 years) or systematic screening (in people above 75 years) by using clinical examination, followed by an ECG, 24-hour ECG monitoring …
Calcium and vitamin D supplement: right or wrong? - Heart
Intuitively, one might think that supplementing vitamins and minerals would be the right thing to do especially in older and comorbid people. Every year, billions of dollars are spent in this belief.1 However, we may all be wrong. A present study in this journal demonstrates a significantly increased cardiovascular (CV) mortality in elderly patients supplementing calcium, be it with or …
Advancing the access to cardiovascular diagnosis and treatment …
Despite significant progress in cardiovascular pharmacotherapy and interventional strategies, cardiovascular disease (CVD), in particular ischaemic heart disease, remains the leading cause of morbidity and mortality among women in the UK and worldwide. Women are underdiagnosed, undertreated and under-represented in clinical trials directed at management strategies for …
Clinical relevance of arrhythmias during sleep: guidance for ... - Heart
REM sleep occurs at approximately 90 minute intervals, encompasses most dream activity, and is characterised by rapid eye movements and reduced voluntary muscle activity. Studies of individuals free of cardiac disease show that sinus bradycardia, sinus pauses, and type 1 second degree atrioventricular (AV) block are common during sleep (table 1 ...
Recent advances in percutaneous coronary intervention - Heart
Percutaneous coronary intervention (PCI) continues to advance at pace with an ever-broadening indication. In this article we will review the recent technological advances in PCI that have enabled more complex coronary disease to be treated. The choice of revascularisation strategy must take into account the evidence—just because we can treat by PCI does not necessarily mean we …
Resting heart rate: what is normal?
Resting heart rate (RHR) is a clinical parameter easily measurable with typical value between 50 and 90 beats per minute (bpm) that varies during the day with a night-time decrease.1 RHR can go down to 30 bpm in those with good physical condition, but RHR is also partly genetically determined, with slightly higher values in women than in men.2 The interpretation of RHR by …
Atherosclerotic cardiovascular disease risk prediction: current state ...
### Learning objectives Cardiovascular disease (CVD) is the leading cause of mortality worldwide, resulting in ~18 million deaths annually.1 Atherosclerotic CVD (ASCVD) accounts for four out of every five cardiovascular (CV) deaths, one-third of which are premature.1 From 2010 to 2020, there was a global increase of ~19% in CV deaths.1 The economic burden of CVD on …